About 3,300 women a year may benefit from decision to approve ribociclib

Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance.

The National Institute for Health and Care Excellence (Nice) has approved the drug – ribociclib , also known as Kisqali – for routine use by the NHS in England and Wales. It said around 3,300 women a year with advanced breast cancer could benefit from the decision.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

‘A tremendous legacy’: Jenni Murray ends her tenure on BBC’s Woman’s Hour

Warm tributes were paid to the long-serving host of the flagship Radio…

Mark Meadows’ associate threatened ex-White House aide before her testimony

It was the second warning Cassidy Hutchinson had received before her deposition,…

I’ve been unfairly targeted, says academic at heart of National Trust ‘woke’ row

Professor warns of ‘political agenda’ to discredit researchers exploring slavery links The…

Ex-boss urges John Lewis not to change staff ownership model

West Midlands mayor Andy Street says it would be a tragedy, as…